vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and La Rosa Holdings Corp. (LRHC). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $20.2M, roughly 1.5× La Rosa Holdings Corp.). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -32.1%, a 4.7% gap on every dollar of revenue. On growth, La Rosa Holdings Corp. posted the faster year-over-year revenue change (3.2% vs -4.5%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.
LFCR vs LRHC — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $20.2M |
| Net Profit | $-10.0M | $-5.5M |
| Gross Margin | 25.0% | 8.4% |
| Operating Margin | -9.9% | -24.7% |
| Net Margin | -32.1% | -27.4% |
| Revenue YoY | -4.5% | 3.2% |
| Net Profit YoY | -52.0% | -125.7% |
| EPS (diluted) | $-0.29 | $-5.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $31.1M | $20.2M | ||
| Q2 25 | — | $23.2M | ||
| Q1 25 | $35.2M | $17.5M | ||
| Q4 24 | $32.6M | $17.7M | ||
| Q3 24 | $24.7M | $19.6M | ||
| Q2 24 | — | $19.1M | ||
| Q1 24 | $35.7M | $13.1M | ||
| Q4 23 | $30.1M | — |
| Q3 25 | $-10.0M | $-5.5M | ||
| Q2 25 | — | $78.4M | ||
| Q1 25 | $-14.8M | $-95.7M | ||
| Q4 24 | $-6.6M | $-5.1M | ||
| Q3 24 | $-16.2M | $-2.5M | ||
| Q2 24 | — | $-2.3M | ||
| Q1 24 | $15.6M | $-4.6M | ||
| Q4 23 | $14.2M | — |
| Q3 25 | 25.0% | 8.4% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | 28.0% | 8.8% | ||
| Q4 24 | 34.0% | 8.9% | ||
| Q3 24 | 21.8% | 8.3% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | 33.3% | 8.9% | ||
| Q4 23 | 33.0% | — |
| Q3 25 | -9.9% | -24.7% | ||
| Q2 25 | — | -10.6% | ||
| Q1 25 | -25.7% | -26.7% | ||
| Q4 24 | -6.0% | -17.1% | ||
| Q3 24 | -46.9% | -8.9% | ||
| Q2 24 | — | -9.7% | ||
| Q1 24 | -2.5% | -35.0% | ||
| Q4 23 | -4.9% | — |
| Q3 25 | -32.1% | -27.4% | ||
| Q2 25 | — | 337.8% | ||
| Q1 25 | -42.0% | -546.5% | ||
| Q4 24 | -20.2% | -28.7% | ||
| Q3 24 | -65.7% | -12.5% | ||
| Q2 24 | — | -12.2% | ||
| Q1 24 | 43.8% | -35.1% | ||
| Q4 23 | 47.2% | — |
| Q3 25 | $-0.29 | $-5.44 | ||
| Q2 25 | — | $15.25 | ||
| Q1 25 | $-0.47 | $-5.86 | ||
| Q4 24 | $-0.25 | $28.54 | ||
| Q3 24 | $-0.53 | $-16.49 | ||
| Q2 24 | — | $-12.49 | ||
| Q1 24 | $0.42 | $-0.35 | ||
| Q4 23 | $0.39 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $4.0M |
| Total DebtLower is stronger | $136.0M | $642.8K |
| Stockholders' EquityBook value | $-10.5M | $1.6M |
| Total Assets | $235.2M | $21.7M |
| Debt / EquityLower = less leverage | — | 0.41× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $18.9M | $4.0M | ||
| Q2 25 | — | $5.1M | ||
| Q1 25 | $5.4M | $2.9M | ||
| Q4 24 | $9.5M | $1.4M | ||
| Q3 24 | — | $1.8M | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | — | $1.1M | ||
| Q4 23 | — | — |
| Q3 25 | $136.0M | $642.8K | ||
| Q2 25 | — | $644.3K | ||
| Q1 25 | $124.9M | $645.9K | ||
| Q4 24 | $111.3M | $647.6K | ||
| Q3 24 | $106.3M | $649.2K | ||
| Q2 24 | — | $650.8K | ||
| Q1 24 | $97.1M | $652.4K | ||
| Q4 23 | $92.9M | — |
| Q3 25 | $-10.5M | $1.6M | ||
| Q2 25 | — | $3.4M | ||
| Q1 25 | $2.2M | $-87.5M | ||
| Q4 24 | $15.4M | $2.6M | ||
| Q3 24 | $-3.9M | $5.0M | ||
| Q2 24 | — | $4.7M | ||
| Q1 24 | $17.7M | $5.6M | ||
| Q4 23 | $1.4M | — |
| Q3 25 | $235.2M | $21.7M | ||
| Q2 25 | — | $22.9M | ||
| Q1 25 | $237.7M | $21.0M | ||
| Q4 24 | $255.4M | $19.4M | ||
| Q3 24 | $246.8M | $19.7M | ||
| Q2 24 | — | $18.7M | ||
| Q1 24 | $246.2M | $16.3M | ||
| Q4 23 | $245.8M | — |
| Q3 25 | — | 0.41× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | 0.25× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | 5.49× | 0.12× | ||
| Q4 23 | 65.35× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-1.3M |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $1.8M | $-1.3M | ||
| Q2 25 | — | $-1.4M | ||
| Q1 25 | $1.2M | $-3.5M | ||
| Q4 24 | $-6.1M | $-1.1M | ||
| Q3 24 | $-613.0K | $-591.6K | ||
| Q2 24 | — | $-803.1K | ||
| Q1 24 | $-1.4M | $-538.3K | ||
| Q4 23 | $1.3M | — |
| Q3 25 | $25.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.8M | — | ||
| Q4 23 | $-3.0M | — |
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -12.1% | — | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -16.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -21.8% | — | ||
| Q4 23 | -9.9% | — |
| Q3 25 | 5.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.8% | — | ||
| Q4 23 | 14.1% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — | ||
| Q4 23 | 0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
